Novartis in $1.68B Blood Unit Deal With Grifols

Nov. 11 (Bloomberg) -- Bloomberg’s Ryan Chilcote reports that Novartis has agreed to sell a blood transfusion diagnostics unit to Grifols for $1.68 billion in the company’s biggest asset sale in five years. He speaks on Bloomberg Television’s “The Pulse.”

Horizons to Launch First Medical Marijuana ETF
43:08 - Horizons is the latest company trying to cash in on the marijuana industry. The firm is launching the first medical marijuana ETF on the TSX next week. Units have been conditionally approved for listing and are expected to begin trading on April 5th. Steven Hawkins, president and co-CEO of Horizons ETFs speaks on "Bloomberg Markets Canada." (Source: Bloomberg)
  • Laurentian Adds Advisers as Branches Turn to 'Clinics'
  • Bloomberg Markets Trump: First 100 Days 3/29
  • Canadian Western Eyes M&A Amid Diversification Efforts